Athersys, Inc. (ATHXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Athersys Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -3.771M |
| June 30, 2023 | -12.92M |
| March 31, 2023 | -7.811M |
| December 31, 2022 | -13.00M |
| September 30, 2022 | -13.67M |
| June 30, 2022 | -23.65M |
| March 31, 2022 | -22.22M |
| December 31, 2021 | -21.71M |
| September 30, 2021 | -16.18M |
| June 30, 2021 | -22.60M |
| March 31, 2021 | -26.47M |
| December 31, 2020 | -22.21M |
| September 30, 2020 | -22.54M |
| June 30, 2020 | -18.37M |
| March 31, 2020 | -15.64M |
| December 31, 2019 | -9.923M |
| September 30, 2019 | -12.02M |
| June 30, 2019 | -9.688M |
| March 31, 2019 | -12.96M |
| December 31, 2018 | -11.32M |
| September 30, 2018 | -9.74M |
| June 30, 2018 | 6.933M |
| March 31, 2018 | -10.16M |
| December 31, 2017 | -13.10M |
| September 30, 2017 | -7.243M |
| Date | Value |
|---|---|
| June 30, 2017 | -6.267M |
| March 31, 2017 | -5.631M |
| December 31, 2016 | -7.127M |
| September 30, 2016 | -6.004M |
| June 30, 2016 | -6.956M |
| March 31, 2016 | 4.75M |
| December 31, 2015 | 3.592M |
| September 30, 2015 | -6.497M |
| June 30, 2015 | -1.035M |
| March 31, 2015 | -12.48M |
| December 31, 2014 | -6.554M |
| September 30, 2014 | -4.719M |
| June 30, 2014 | 0.675M |
| March 31, 2014 | -11.48M |
| December 31, 2013 | -9.795M |
| September 30, 2013 | -5.614M |
| June 30, 2013 | -5.946M |
| March 31, 2013 | -9.388M |
| December 31, 2012 | -3.237M |
| September 30, 2012 | -3.449M |
| June 30, 2012 | -3.713M |
| March 31, 2012 | -4.336M |
| December 31, 2011 | -4.252M |
| September 30, 2011 | -2.341M |
| June 30, 2011 | -3.223M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |